KLISBIO
KLISBio is a clinical-stage regenerative medicine company focused on developing innovative technology platforms based entirely on natural silk fibroin. The company, headquartered in Milan, Italy, currently has several assets under development, such as vascular graft, bone graft substitutes, rotator cuff repair, drug release, and a first-in-human study on nerve repair that is ongoing at the University of Zurich, Switzerland
KLISBIO
Industry:
Biotechnology Health Care Life Science Medical Device
Founded:
2014-07-31
Address:
Lomazzo, Lombardia, Italy
Country:
Italy
Website Url:
http://www.klis.bio
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
10.56 M EUR
Technology used in webpage:
SPF Google Apps For Business BlueHost BlueHost DNS BlueHost Mail
Similar Organizations
Acthera Therapeutics
Acthera Therapeutics is developing an innovative nanotechnology-based platform for the controlled and targeted drug delivery
Amwise Diagnostic
Amwise Diagnostic is a leader in precision medicine technology for cancer.
Morphodyne
Morphodyne is an unique 3D bioprinting technology platform.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Current Employees Featured
Founder
Investors List
Principia SGR
Principia SGR investment in Convertible Note - KLISBio
Principia SGR
Principia SGR investment in Series A - KLISBio
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - KLISBio
Official Site Inspections
http://www.klis.bio
- Host name: cluster-a.redirect.pizza
- IP address: 89.41.169.49
- Location: Netherlands
- Latitude: 52.3824
- Longitude: 4.8995
- Timezone: Europe/Amsterdam
